Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture X Li, L Nadauld, A Ootani, DC Corney, RK Pai, O Gevaert, MA Cantrell, ... Nature medicine 20 (7), 769-777, 2014 | 462 | 2014 |
Chemodetection and destruction of host urea allows Helicobacter pylori to locate the epithelium JY Huang, EG Sweeney, M Sigal, HC Zhang, SJ Remington, MA Cantrell, ... Cell host & microbe 18 (2), 147-156, 2015 | 196 | 2015 |
c-Jun N-terminal kinases mediate a wide range of targets in the metastatic cascade ND Ebelt, MA Cantrell, CL Van Den Berg Genes & cancer 4 (9-10), 378-387, 2013 | 71 | 2013 |
Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model P Chen, JF O'Neal, ND Ebelt, MA Cantrell, S Mitra, A Nasrazadani, ... PloS one 5 (5), e10443, 2010 | 64 | 2010 |
Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration TS Kaoud, S Mitra, S Lee, J Taliaferro, M Cantrell, KD Linse, ... ACS chemical biology 6 (6), 658-666, 2011 | 57 | 2011 |
Organoid modeling for cancer precision medicine MA Cantrell, CJ Kuo Genome medicine 7, 1-3, 2015 | 48 | 2015 |
c-Jun N-terminal kinase 2 (JNK2) enhances cell migration through epidermal growth factor substrate 8 (EPS8) S Mitra, JS Lee, M Cantrell, CL Van Den Berg Journal of Biological Chemistry 286 (17), 15287-15297, 2011 | 41 | 2011 |
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression MA Cantrell, ND Ebelt, AD Pfefferle, CM Perou, CL Van Den Berg Oncotarget 6 (14), 11863, 2015 | 13 | 2015 |
Gastrointestinal organoid cultures for functional evaluation of oncogenic loci. AA Salahudeen, X Li, M Cantrell, CJ Kuo Journal of Clinical Oncology 33 (3_suppl), 85-85, 2015 | 4 | 2015 |
Functional screening of amplification outlier oncogenes in organoid models of early tumorigenesis AA Salahudeen, JA Seoane, K Yuki, AT Mah, AR Smith, K Kolahi, M Sean, ... Cell reports 42 (11), 2023 | 3 | 2023 |
Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite US study C Willis, H Bauer, TH Au, J Menon, S Unni, D Tran, Z Rivers, W Akerley, ... Oncotarget 13, 257, 2022 | 2 | 2022 |
Pan-cancer organoid validation of tumor outlier chromosomal amplification events AA Salahudeen, K Yuki, JA Seoane, AT Mah, AR Smith, K Kolahi, ... bioRxiv, 2021.10. 05.463147, 2021 | 1 | 2021 |
Addendum: Real-world survival analysis by tumor mutational burden in non-small cell lung cancer: a multisite US study C Willis, H Bauer, TH Au, J Menon, S Unni, D Tran, Z Rivers, W Akerley, ... Oncotarget 13, 1306, 2022 | | 2022 |
Abstract LB-34: 3-Dimensional air-liquid interface organoid culture of primary human tumor biopsies JT Neal, M Cantrell, P Rack, CJ Kuo Cancer Research 74 (19_Supplement), LB-34-LB-34, 2014 | | 2014 |
JNK2 inhibits luminal cell commitment in normal mammary glands and tumors MA Cantrell | | 2013 |
PD08-01: JNK2 Regulates Mammary Lineage Differentiation in Tumors and Normal Glands through Notch1 and p53. MA Cantrell, ND Ebelt, BCL Van Den Cancer Research 71 (24_Supplement), PD08-01-PD08-01, 2011 | | 2011 |
cJun N-terminal Kinase 2 (JNK2) enhances cell migration through Epidermal Growth Factor Substrate 8 (EPS8) Shreya Mitra1, 2, Ju-Seog Lee2, Michael Cantrell3, Carla Lynn Van Den … S Mitra, JS Lee, M Cantrell | | 2011 |
Abstract P5-06-15: JNK2 Regulates Mammary Epithelial Cell Differentiation Through Inhibition of p53 and Notch-1 Expression M Cantrell, ND Ebelt, CL Van Den Berg Cancer Research 70 (24_Supplement), P5-06-15-P5-06-15, 2010 | | 2010 |